References
- 1. Shi F, Cavitt J, Audus KL. 21-aminosteroid and 2-(aminomethyl) chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radic Biol Med. 1995;19:349-57.
- 2. Tsompos C, Panoulis C, Toutouzas K, Zografos G, Papalois A. The Hypoglucemic Effect of the Antioxidant Drug “U-74389g” during Ischemia Reperfusion Injury in Rats. Int J Diabetes Clin Res. 2015;2:1-4.
- 3. Barshishat-Kupper M, Mungunsukh O, Tipton AJ, et al. Captopril modulates hypoxia inducible factors and erythropoietin responses in a murine model of total body irradiation. Exp Hematol. 2011;39:293-304.
- 4. Weltert L, D’Alessandro S, Nardella S, et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg. 2010;139:621-7.
- 5. Gardin C, Fenaux P. Supportive care including growth factors in myelodysplastic syndromes. Rev Clin Exp Hematol. 2004;8:E3.
- 6. Ferber A, Minior VK, Bornstein E, et al. Fetal “nonreassuring status” is associated with elevation of nucleated red blood cell counts and interleukin-6. Am J Obstet Gynecol. 200;192:1427-9.
- 7. Fujishiro N, Endo Y, Warashina A, et al. Mechanisms for hypoxia detection in O2-sensitive cells. Jpn J Physiol. 2004;54:109-23.
- 8. Vatansever U, Acunaş B, Demir M, et al. Nucleated red blood cell counts and erythropoietin levels in high-risk neonates. Pediatr Int. 2002;44:590-5.
- 9. Singbartl G. Adverse events of erythropoietin in long-term and in acute/short-term treatment. Clin Investig. 1994;72(6 Suppl):S36-43.
- 10. Hara H, Ogawa M. Erythropoietic precursors in mice under erythropoietic stimulation and suppression. Exp Hematol. 1977;5:141-8.
- 11. Haddad J Jr, Egusa K, Takoudes TG. Effects of 21-aminosteroid U-74389G on acute otitis media in a guinea pig model. Otolaryngol Head Neck Surg. 1998;118:44-8.